Nutex Health (NASDAQ:NUTX) Reaches New 1-Year High – Time to Buy?

Posted by Brian Himes on Sep 14th, 2026

Nutex Health Inc. (NASDAQ:NUTX – Get Free Report)’s share price hit a new 52-week high on Monday . The company traded as high as $204.06 and last traded at $206.8640, with a volume of 11840 shares. The stock had previously closed at $195.20.

Analyst Ratings Changes

Several brokerages recently issued reports on NUTX. Zacks Research upgraded Nutex Health from a “hold” rating to a “strong-buy” rating in a report on Monday, August 24th. B. Riley Financial upped their target price on Nutex Health from $290.00 to $325.00 and gave the stock a “buy” rating in a research report on Friday, September 4th. Lake Street Capital reiterated a “buy” rating and issued a $310.00 target price (up from $235.00) on shares of Nutex Health in a research note on Tuesday, August 11th. Wall Street Zen downgraded Nutex Health from a “buy” rating to a “hold” rating in a report on Saturday, September 5th. Finally, B Riley reissued a “buy” rating on shares of Nutex Health in a research report on Friday, September 4th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $317.50.

Read Our Latest Research Report on NUTX

Nutex Health Stock Performance

The company has a debt-to-equity ratio of 0.59, a current ratio of 5.00 and a quick ratio of 4.96. The stock has a 50-day moving average price of $176.69 and a 200-day moving average price of $140.29. The firm has a market capitalization of $1.43 billion, a PE ratio of 8.19 and a beta of 0.28.

Nutex Health (NASDAQ:NUTX – Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, beating analysts’ consensus estimates of $4.95 by $4.43. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%.The firm had revenue of $210.75 million during the quarter, compared to analyst estimates of $215.03 million. On average, research analysts expect that Nutex Health Inc. will post 27.58 EPS for the current fiscal year.

Institutional Trading of Nutex Health

A number of hedge funds have recently made changes to their positions in NUTX. WINTON GROUP Ltd bought a new stake in shares of Nutex Health in the second quarter worth $237,000. Allworth Financial LP boosted its stake in Nutex Health by 41.0% during the 2nd quarter. Allworth Financial LP now owns 203 shares of the company’s stock valued at $35,000 after acquiring an additional 59 shares during the last quarter. Arizona State Retirement System acquired a new position in Nutex Health during the 2nd quarter worth $230,000. Corient Private Wealth LP increased its position in shares of Nutex Health by 5.1% in the 2nd quarter. Corient Private Wealth LP now owns 6,684 shares of the company’s stock worth $1,142,000 after purchasing an additional 325 shares during the last quarter. Finally, Amundi bought a new stake in shares of Nutex Health in the 2nd quarter worth about $378,000. Institutional investors and hedge funds own 5.32% of the company’s stock.

About Nutex Health

(Get Free Report)

Nutex Health Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, outpatient facilities and physician practices. The company focuses on delivering emergency, inpatient and outpatient care through community-based healthcare facilities, including micro-hospitals designed to provide essential hospital services in convenient local settings.

Its services may include emergency medicine, primary care, specialty care, diagnostic testing, imaging, laboratory services and other ancillary healthcare offerings.